Abstract:Polydopamine (PDA)-coated nanoparticles (NPs) are emerging carriers of therapeutic agents for nanomedicine applications due to their biocompatibility and abundant entry to various cell types, yet it remains unknown whether their cellular entry engages cell-surface receptors. As monomeric dopamine (DA) is an endogenous ligand of dopamine receptor and raw ingredient of PDA, we elucidate the interaction between polyethylene glycol-stabilized, PDA-coated gold NPs (@PEG NPs) and dopamine receptors, particularly D2 (D2DR). After proving the binding of @PEG NPs to recombinant and cellular D2DR, we employ antibody blocking, gene knockdown, and gene overexpression to establish the role of D2DR in the cellular uptake of @PEG NPs in vitro. By preparing a series of PEG-coated AuNPs that contain different structural analogues of DA ( NPs), we demonstrate that catechol and amine groups collectively enhance the binding of NPs to D2DR and their cellular uptake. By intravenously injecting @PEG NPs to Balb/c mice, we reveal their in vivo binding to D2DR in the liver by competitive inhibition and immunohistochemistry together with their preferential association to D2DR-rich resident Kupffer cells by flow cytometry, a result consistent with the profuse expression of D2DR by resident Kupffer cells. Catechol and amine groups jointly contribute to the preferential association of NPs to D2DR-rich Kupffer cells. Our data highlight the importance of D2DR expression and DA-related functional groups in mediating the cell–nano interactions of PDA-based nanomedicines.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c06081.Additional detailed experimental section, physicochemical characterization of @PEG NPs and NPs, colloidal stability of NPs in medium and blood serum, additional modified ELISA binding experiments, cytotoxicity of NPs, quantification of absorbed proteins on NPs, Western blotting analysis of the expression of DR, pharmacological blocking experiments, cellular uptake kinetics and intracellular trafficking of @PEG NPs, characterization of HS-PEG1000-X, additional confocal reflectance images for cellular uptake of NPs, silver-enhanced histological images of the tissue-level distribution of NPs, gating strategies for different cell populations in the liver for flow cytometry analysis, effect of fluorophore labeling on cellular uptake and organ-level distribution of NPs, additional confocal and TEM images of the spleen (PDF)This article has not yet been cited by other publications.

Robust polydopamine nano/microcapsules and their loading and release behavior.

Highly Selective Uptake and Release of Charged Molecules by Ph‐responsive Polydopamine Microcapsules

Preparation and Properties of a Ph-Responsive PDMS Platform

Polydopamine Coatings in Confined Nanopore Space: Toward Improved Retention and Release of Hydrophilic Cargo

Responsive Complex Capsules Prepared with Polymerization of Dopamine, Hydrogen-Bonding Assembly, and Catechol Dismutation

Rapid Deposition of Uniform Polydopamine Coatings on Nanoparticle Surfaces with Controllable Thickness.

Polydopamine Nanobottles with Photothermal Capability for Controlled Release and Related Applications

Preparation of Polydopamine Nanocapsules in a Miscible Tetrahydrofuran–buffer Mixture

Fabrication of Amphiphilic Porous PDVB-PAA Janus Nanoparticles: Formation Mechanism, Simultaneous Loading and Regulated Release of Hydrophobic and Hydrophilic Cargos

Mixed-Solvent-Mediated Strategy for Enhancing Light Absorption of Polydopamine and Adhesion Persistence of Dopamine Solutions

A versatile ethanol-mediated polymerization of dopamine for efficient surface modification and the construction of functional core-shell nanostructures

Polydopamine Microcapsules with Different Wall Structures Prepared by a Template-Mediated Method for Enzyme Immobilization.

Engineering Fluorescent Poly(dopamine) Capsules.

Controlled Architecture of Hybrid Polymer Nanocapsules with Tunable Morphologies by Manipulating Surface-Initiated ARGET ATRP from Hydrothermally Modified Polydopamine

Polydopamine Nanosystems in Drug Delivery: Effect of Size, Morphology, and Surface Charge

Controlled Fabrication of Polydopamine Nanocapsules via Polymerization-Induced Self-Assembly

Interfacially active polydopamine for nanoparticle stabilized nanocapsules in a one-pot assembly strategy toward efficient drug delivery

Investigation of Release Kinetics of DOX from Polydopamine Nanocapsules Prepared by Hard Template Method

Enhanced Drug Loading Capacity of Polypyrrole Nanowire Network for Controlled Drug Release

Dopamine Receptor-Mediated Binding and Cellular Uptake of Polydopamine-Coated Nanoparticles

Morphologically Controlled Bioinspired Dopamine‐Polypyrrole Nanostructures with Tunable Electrical Properties